• APEX2 Regulates TERT Expression via DNA Repeat Elements in h

  2026-07-28

  This study demonstrates that APEX2, but not APEX1, is essential for efficient TERT gene expression in human embryonic stem cells and melanoma cells. By uncovering a novel link between DNA repair enzymes and telomerase regulation at repetitive DNA elements, the research provides new directions for understanding stem cell maintenance and cancer biology.

• CK2 and ERK8 Inhibitor: Precision Tools for Phase Separation

  2026-07-28

  Explore how the CK2 and ERK8 inhibitor, a potent small molecule inhibitor, empowers advanced studies of protein phosphorylation and condensate biology. This article uniquely bridges kinase modulation with cutting-edge phase separation assays, offering actionable insights for biochemical research.

• Nirmatrelvir (PF-07321332): SARS-CoV-2 3CL Protease Inhibito

  2026-07-27

  Nirmatrelvir (PF-07321332) is a small-molecule inhibitor targeting the essential SARS-CoV-2 3CL protease, a validated drug target for COVID-19 research. This compound, provided by APExBIO as product B8579, has robust purity and protocol-ready features, making it a cornerstone for antiviral therapeutics research and SARS-CoV-2 replication inhibition.

• Caffeic Acid Phenethyl Ester: Precision in Neurodegeneration

  2026-07-27

  Caffeic Acid Phenethyl Ester (CAPE) brings unmatched specificity as an NF-κB inhibitor, empowering neurodegeneration research with reproducible, quantifiable results. Here, we decode advanced workflows and troubleshooting strategies to maximize CAPE’s performance, with practical insights for both in vitro and in vivo systems.

• FCCP in Mitochondrial Biology: Protocols & Troubleshooting I

  2026-07-26

  FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) empowers researchers to dissect mitochondrial function and HIF pathway modulation in cancer and metabolic studies. This guide delivers actionable workflows, data-driven protocol enhancements, and troubleshooting strategies to maximize the reliability and reproducibility of FCCP-driven assays.

• Phosphatase Inhibitor Cocktail 3: Precision in Phosphoprotei

  2026-07-25

  Phosphatase Inhibitor Cocktail 3 (100X in DMSO) enables reliable protein phosphorylation preservation by potently inhibiting serine/threonine and alkaline phosphatases. This APExBIO reagent ensures accurate phosphoprotein analysis, essential for signaling studies. Its robust formulation supports workflows such as Western blotting and immunoprecipitation.

• Phosphatase Inhibitor Cocktail 2: Reliable Phosphorylation P

  2026-07-24

  Phosphatase Inhibitor Cocktail 2 (100X in ddH2O) streamlines workflows by preserving protein phosphorylation across diverse experimental platforms. Its broad-spectrum efficacy and user-friendly formulation empower high-confidence signal transduction studies and reproducible kinase assays.

• Sulfo-NHS-SS-Biotin: Advanced Cell Surface Protein Labeling

  2026-07-24

  Unlock precise, reversible cell surface mapping with Sulfo-NHS-SS-Biotin. This APExBIO kit enables high-fidelity protein and antibody biotinylation for purification, interactomics, and dynamic studies—empowering workflows that dissect emerging glycoRNA–protein domains and beyond.

• Biotin Azide: Advancing Bio-Orthogonal Labeling in Wnt Signa

  2026-07-23

  Explore how Biotin Azide propels precision biotinylation in translational research, enabling mechanistic dissection of complex pathways such as cholesterol-mediated Wnt/β-catenin signaling in cancer. This article bridges molecular mechanism, practical protocol guidance, and forward-looking strategy for biomedical innovators.

• Tiamulin (Thiamutilin): Optimizing Veterinary and In Vitro A

  2026-07-23

  Tiamulin (Thiamutilin) seamlessly bridges potent antibacterial action in veterinary medicine with advanced in vitro anti-inflammatory assays. Discover practical protocols, troubleshooting strategies, and the latest structural insights that maximize efficacy while addressing resistance and translational challenges.

• Gemcitabine HCl: Protocol Optimization for Pancreatic Tumor

  2026-07-22

  Gemcitabine HCl delivers unparalleled precision in DNA replication inhibition and apoptosis induction in cancer research, especially within pancreatic cancer models. This article translates advanced multianimal MRI-guided workflows and troubleshooting strategies for maximizing reproducibility and throughput, setting a new benchmark for preclinical drug evaluation.

• Sulfo-Cy5 Carboxylic Acid: A Benchmark Fluorescent Dye for L

  2026-07-22

  Sulfo-Cy5 carboxylic acid is a sulfonated, hydrophilic fluorescent dye optimized for aqueous protein and peptide labeling. Its high water solubility and reduced fluorescence quenching support robust imaging in neuroscience and mucosal immunity research. APExBIO's formulation delivers industry-leading purity and reproducibility.

• Acetylation-Regulated Spliceosome Drives HCC Therapy Respons

  2026-07-21

  This study uncovers the role of SmD2 acetylation in modulating spliceosome function and DNA repair in hepatocellular carcinoma (HCC). The findings highlight how HDAC2 inhibition enhances the efficacy of PARP inhibitors, offering a new combination strategy for HCC treatment.

• Medroxyprogesterone Acetate in Decidualization and Lipid Met

  2026-07-21

  Discover how Medroxyprogesterone acetate advances endometrial and lipid metabolism research, with a focus on recent mechanistic findings and practical assay strategies. This article offers a unique, evidence-driven perspective for optimizing hormone and reproductive studies.

• WNT5a/GSK3/β-Catenin Axis Regulates FAP Adipogenesis in Musc

  2026-07-20

  This study elucidates the regulatory role of the WNT5a/GSK3/β-catenin signaling axis in the adipogenic differentiation of skeletal muscle fibro/adipogenic progenitors (FAPs). The findings advance mechanistic understanding and suggest new strategies for limiting pathological fat infiltration in muscle disorders.

453 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page